Soros Fund Management »

Aeglea Biotherapeutics shares owned by Soros Fund Management

Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Soros Fund Management from 13F filings

Historical chart of Soros Fund Management investment in Aeglea Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aeglea Biotherapeutics held by Soros Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeglea Biotherapeutics by Soros Fund Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $3.4M 145k 23.51
2024-03-31 $1.1M 30k 37.93

More positions owned by Soros Fund Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Rivian Automotive Note 4.625% 3/1 (Principal)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Astrazeneca Sponsored Adr (AZN)
Apple (AAPL)
Westrock (WRK)
Alphabet Cap Stk Cl A (GOOGL)
Aercap Holdings Nv SHS (AER)
Wayfair Note 1.000% 8/1 (Principal)
Axonics Modulation Technolog (AXNX)
Ishares Tr 20 Yr Tr Bd Etf Put Option (TLT)
Dish Network Corporation Note 12/1 (Principal)
Vaneck Etf Trust Semiconductr Etf Put Option (SMH)
Cerevel Therapeutics Hldng I (CERE)
Costco Wholesale Corporation Put Option (COST)

View all positions for Soros Fund Management

Top funds holding Aeglea Biotherapeutics

FMR
Fairmount Funds Management
Perceptive Advisors
VR Adviser
Braidwell
BlackRock
Rtw Investments
Commodore Capital
Vanguard Group
venBio Select Advisor
Deep Track Capital
State Street Corporation
Adage Capital Partners GP
Goldman Sachs Group
Wellington Management Company

View all funds holding Aeglea Biotherapeutics